Krka, d. d. (WSE:KRK)

Market Cap	26.60B
Revenue (ttm)	8.37B
Net Income (ttm)	1.62B
Shares Out	n/a
EPS (ttm)	52.70
PE Ratio	16.46
Forward PE	16.17
Dividend	35.03 (3.89%)
Ex-Dividend Date	Jul 22, 2025

Volume	63
Average Volume	126
Open	860.00
Previous Close	874.00
Day's Range	860.00 - 876.00
52-Week Range	574.00 - 990.00
Beta	0.49
RSI	49.03
Earnings Date	Nov 13, 2025

About Krka, d. d.

Krka, d. d., a generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally. The company’s prescription pharmaceuticals include medicines for the treatment of cardiovascular, gastrointestinal tract and metabolism, central nervous system, oncology, pain relief, antiinfectives for systemic use, antidiabetics, and other products. It provides non-prescription prod...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1954
• Employees: 11,308
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: KRK

Financial Performance

In 2024, Krka, d. d.'s revenue was 1.91 billion, an increase of 5.71% compared to the previous year's 1.81 billion. Earnings were 356.99 million, an increase of 13.71%.

Financial numbers in EUR